DIANA PEREZ-NUNEZ: Open Payments
NPI 1609304450 · CORAL SPRINGS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,357 in 147 payments from 19 companies in 2025. Trend: 2023 $836 · 2024 $1,830 · 2025 $3,357
Food & beverage: $3,242Education: $115
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $518 |
| Otsuka America Pharmaceutical, Inc. | 13 | $272 |
| Almatica Pharma LLC | 11 | $252 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $237 |
| Indivior Inc. | 5 | $231 |
| Alkermes, Inc. | 11 | $230 |
| Teva Pharmaceuticals USA, Inc. | 8 | $221 |
| E.R. Squibb & Sons, L.L.C. | 6 | $216 |
| Collegium Pharmaceutical, Inc. | 11 | $183 |
| Axsome Therapeutics, Inc. | 10 | $175 |
Products named: VRAYLAR, LOREEV XR, CAPLYTA, SUBLOCADE, COBENFY, REXULTI, Jornay PM, Auvelity.
Industry payments across FL — which companies pay providers there.
